[1]
“The Crossroad between Intellectual Property and Clinical Trials: Balancing Incentives for Innovation with Access to Healthcare”, JIPR, vol. 28, no. 4, pp. 284–292, Jun. 2023, doi: 10.56042/jipr.v28i4.77.